Pharosyn is an AI-powered competitive intelligence platform for the pharma and biotech sectors.
Pharosyn has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
Pharosyn's investors include Entrepreneurs First, Moonfire Ventures, Transpose Platform Management, General Advance.
Pharosyn is headquartered in Newark, United States.
Pharosyn is an AI-powered competitive intelligence platform for the pharma and biotech sectors.
Pharosyn is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pharosyn — Funding & Investors." VCBacked, September 2, 2026, https://www.vcbacked.co/company/pharosyn. Accessed October 1, 2026.
VCBacked. (2026). Pharosyn — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/pharosyn
{{cite web |title=Pharosyn — Funding & Investors |url=https://www.vcbacked.co/company/pharosyn |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated